CD8A and lung carcinoma: In a recent trial in mouse models, prophylactic vaccination of exosomes derived from murine embryonic stem cells (ESCs) engineered to produce GM-CSF significantly blocked outgrowth of implanted lung carcinoma and induced robust CD8+ and Th1 responses [111].